TTM
$1.17B
YoY change
+10.1%
5Y CAGR
+7.5%
Peak year (2021)
$1.17B
Cumulative gross profit
$15.03B
Gross Profit history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: $1.10B
Gross Profit growth chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: +10.1%
Gross Profit history table for West Pharmaceutical Services (WST) from 1985 to 2025
| 2025 | $1.10B | +10.1% | +$101.10M | ||
| 2024 | $1.00B | -11.5% | −$130.50M | ||
| 2023 | $1.13B | -0.5% | −$6.20M | ||
| 2022 | $1.14B | -2.9% | −$34.50M | ||
| 2021 | $1.17B | +52.8% | +$405.50M | ||
| 2020 | $767.90M | +26.1% | +$159.10M | ||
| 2019 | $608.80M | +11.4% | +$62.50M | ||
| 2018 | $546.30M | +6.1% | +$31.50M | ||
| 2017 | $514.80M | +2.8% | +$13.80M | ||
| 2016 | $501.00M | +10.3% | +$46.90M | ||
| 2015 | $454.10M | +1.4% | +$6.20M | ||
| 2014 | $447.90M | +4.3% | +$18.40M | ||
| 2013 | $429.50M | +10.8% | +$41.70M | ||
| 2012 | $387.80M | +14.4% | +$48.80M | ||
| 2011 | $339.00M | +6.7% | +$21.40M | ||
| 2010 | $317.60M | +4.6% | +$14.00M | ||
| 2009 | $303.60M | +0.3% | +$1.00M | ||
| 2008 | $302.60M | +3.7% | +$10.80M | ||
| 2007 | $291.80M | +11.5% | +$30.00M | ||
| 2006 | $261.80M | +35.1% | +$68.00M | ||
| 2005 | $193.80M | +15.7% | +$26.30M | ||
| 2004 | $167.50M | +7.5% | +$11.70M | ||
| 2003 | $155.80M | +32.5% | +$38.20M | ||
| 2002 | $117.60M | +1.3% | +$1.50M | ||
| 2001 | $116.10M | -17.3% | −$24.30M | ||
| 2000 | $140.40M | -22.0% | −$39.60M | ||
| 1999 | $180.00M | +7.5% | +$12.50M | ||
| 1998 | $167.50M | +2.1% | +$3.50M | ||
| 1997 | $164.00M | +4.6% | +$7.20M | ||
| 1996 | $156.80M | +6.1% | +$9.00M | ||
| 1995 | $147.80M | +6.2% | +$8.60M | ||
| 1994 | $139.20M | +10.0% | +$12.60M | ||
| 1993 | $126.60M | +5.1% | +$6.20M | ||
| 1992 | $120.40M | +11.3% | +$12.20M | ||
| 1991 | $108.20M | +6.4% | +$6.50M | ||
| 1990 | $101.70M | -0.3% | −$300.00K | ||
| 1989 | $102.00M | +12.3% | +$11.20M | ||
| 1988 | $90.80M | +15.1% | +$11.90M | ||
| 1987 | $78.90M | +4.6% | +$3.50M | ||
| 1986 | $75.40M | +21.4% | +$13.30M | ||
| 1985 | $62.10M | — | — |
- 2025$1.10B+10.1%
- 2024$1.00B-11.5%
- 2023$1.13B-0.5%
- 2022$1.14B-2.9%
- 2021$1.17B+52.8%
- 2020$767.90M+26.1%
- 2019$608.80M+11.4%
- 2018$546.30M+6.1%
- 2017$514.80M+2.8%
- 2016$501.00M+10.3%
- 2015$454.10M+1.4%
- 2014$447.90M+4.3%
- 2013$429.50M+10.8%
- 2012$387.80M+14.4%
- 2011$339.00M+6.7%
- 2010$317.60M+4.6%
- 2009$303.60M+0.3%
- 2008$302.60M+3.7%
- 2007$291.80M+11.5%
- 2006$261.80M+35.1%
- 2005$193.80M+15.7%
- 2004$167.50M+7.5%
- 2003$155.80M+32.5%
- 2002$117.60M+1.3%
- 2001$116.10M-17.3%
- 2000$140.40M-22.0%
- 1999$180.00M+7.5%
- 1998$167.50M+2.1%
- 1997$164.00M+4.6%
- 1996$156.80M+6.1%
- 1995$147.80M+6.2%
- 1994$139.20M+10.0%
- 1993$126.60M+5.1%
- 1992$120.40M+11.3%
- 1991$108.20M+6.4%
- 1990$101.70M-0.3%
- 1989$102.00M+12.3%
- 1988$90.80M+15.1%
- 1987$78.90M+4.6%
- 1986$75.40M+21.4%
- 1985$62.10M—
Gross Profit values are taken from West Pharmaceutical Services's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current gross profit (TTM) is $1.17B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of West Pharmaceutical Services (WST) gross profit is $1.10B – grew 10.1% year-over-year.
West Pharmaceutical Services gross profit compound annual growth for the 2020–2025 (5 years) window is +7.5%, with mixed annual results across the window.
West Pharmaceutical Services gross profit peaked at $1.17B in 2021; the latest annual figure is $1.10B in 2025 (6.0% below peak).
The highest annual gross profit of $1.17B was reported in 2021. The lowest in the available history was $62.10M in 1985.
West Pharmaceutical Services Gross Profit by Year
West Pharmaceutical Services Gross Profit 2025: $1.10B
West Pharmaceutical Services gross profit in 2025 was $1.10B, grew 10.1% from 2024.
West Pharmaceutical Services Gross Profit 2024: $1.00B
2024's gross profit for West Pharmaceutical Services came in at $1.00B, declined 11.5% below 2023.
West Pharmaceutical Services Gross Profit 2023: $1.13B
West Pharmaceutical Services posted gross profit of $1.13B in 2023, edged down 0.5% below 2022.
West Pharmaceutical Services Gross Profit 2022: $1.14B
In 2022, West Pharmaceutical Services reported gross profit of $1.14B, edged down 2.9% below 2021.
West Pharmaceutical Services Gross Profit 2021: $1.17B
West Pharmaceutical Services gross profit in 2021 was $1.17B.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Gross Profit
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation